跳至主要内容
临床试验/NL-OMON56014
NL-OMON56014招募中不适用

Focus on Energy Metabolism in Arrhythmogenic Cardiomyopathy - FUEL-cardiomyopathy

niversitair Medisch Centrum Utrecht0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria:
  • Affected ACM patients:
  • - Carrier of a (likely) pathogenic PKP2 variant (i.e. class 4 or 5 variant as
  • per American College of Medical Genetics guidelines).
  • - Fulfillment of definite ACM diagnosis as per 2010 Task Force Criteria.
  • - Written informed consent.
  • Preclinical ACM mutation carriers:
  • - Carrier of a (likely) pathogenic PKP2 variant (i.e. class 4 or 5 variant as
  • per American College of Medical Genetics guidelines).
  • - No fulfillment of definite ACM diagnosis as per 2010 Task Force Criteria.
  • - Written informed consent.
  • Healthy controls:
  • - No prior history of cardiac complaints.
  • - Normal echocardiogram.
  • - Normal ECG.
  • - Written informed consent.

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • Affected and preclinical ACM mutation carriers:
  • - Not carrying a (likely) pathogenic PKP2 variant (i.e. class 4 or 5 variant as
  • per American College of Medical Genetics guidelines).
  • - Prior life-threatening arrhythmia during exercise (including sudden cardiac
  • arrest, ventricular fibrillation, sustained ventricular tachycardia,
  • appropriate implantable cardioverter-defibrillator intervention)
  • - Unwilling or unable to provide written informed consent
  • Healthy controls:
  • - Prior history of cardiac complaints
  • - Abnormal echocardiogram
  • - Abnormal ECG
  • - Unwilling or unable to provide written informed consent

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验

Focus on Energy Metabolism in Arrhythmogenic... | 临床试验